Zubrin
tepoxalin
Medicinal product no longer authorised
Medicinal product no longer authorised
Zubrin oral lyophilisates for dogs
Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer
The Netherlands
S-P Veterinary Ltd Breakspear Road South Harefield
Uxbridge UB9 6LS United Kingdom
Zubrin 50 mg oral lyophilisates for dogs Zubrin 100 mg oral lyophilisates for dogs Zubrin 200 mg oral lyophilisates for dogs
Tepoxalin 50 mg / oral lyophilisate
Tepoxalin 100 mg / oral lyophilisate
Tepoxalin 200 mg / oral lyophilisate
Reduction of inflammation and relief of pain caused by acute and chronic musculoskeletal disorders.
Do not use if your dog
is pregnant or lactating or in bitches intended for breeding
has cardiac or hepatic disease
has had gastrointestinal ulceration or bleeding
is hypersensitive to the product
is dehydrated, hypovolaemic or hypotensive, as there is an increased risk of renal toxicity.
Medicinal product no longer authorised
Vomiting or diarrhoea may occur due to treatment. Alopecia and erythema may also occur occasionally.
Typical undesirable side-effects associated with NSAIDs are vomiting, soft faeces/diarrhoea, blood in faeces, reduced appetite, lethargy and renal disorders. If there are such undesirable effects, treatment should be discontinued immediately. In rare cases, particularly in older or in sensitive dogs, these undesirable effects may be serious or fatal.
During clinical trial testing of the product, the incidence of gastrointestinal reactions (diarrhoea/vomiting) occurred in 1 out of 10 animals.
If you notice any other side effects, please inform your veterinary surgeon.
Dogs
The weight of the animal should be accurately determined before start of treatment.
Peel back foil to reveal a single oral lyophilisate in the form of a round tablet. Push the bottom of the blister and the tablet will pop out. Place the tablet in the dog’s mouth. The tablet will disintegrate upon contact with moisture. Keep the mouth of the dog closed for a few seconds to ensure complete tablet wetting. Administer to dogs within 1-2 hours after feeding. When this is not possible, or when dogs resist having the product placed directly into the mouth, put the tablet immediately before administration into a small amount of moistened food, or in a moist treat. Ensure the food or treat containing the medication is completely consumed.
The duration of treatment is dependent on clinical response. After a treatment period of 7-10 days, the condition of the dog should be re-evaluated in order to establish the need for continuation of treatment. Long term treatment should be under regular veterinary supervision.
Ensure hands are dry to prevent the oral lyophilisate from sticking to fingers. Tepoxalin is not water- soluble and becomes very sticky upon wetting. If the oral lyophilisate disintegrates prematurely, wash hands thoroughly.
Not applicable
Keep out of the reach and sight of children.
This veterinary medicinal product does not require any special storage conditions. Do not use after the expiry date, which is stated on the blister.
Medicinal product no longer authorised
The recommended dose should not be exceeded.
Use in animals less than 6 months of age, with a weight below 5 kg, or in aged animals, may involve additional risk. If such use cannot be avoided, close veterinary supervision to monitor for gastrointestinal blood loss is necessary.
Special care should be taken when treating dogs with marked renal insufficiency
Tepoxalin must not be administered in conjunction with other NSAIDs or glucocorticosteroids, diuretics or anticoagulants.
If side effects occur, treatment should be discontinued and the advice of a veterinary surgeon should be sought.
In case of ingestion of a number of oral lyophilisates by a person, the advice of a doctor should be sought immediately.
Ask your veterinary surgeon how to dispose of medicines no longer required. These measures should help to protect the environment.
Detailed information on this product is available on the website of the European Medicines Agency
Not all pack sizes may be marketed.